期刊文献+

人类VIM基因的克隆和真核表达载体的构建

Clone of Human VIM Gene and Construction of VIM Eukaryotic Expression Plasmid
原文传递
导出
摘要 目的:构建VIM(Vimentin)基因的真核表达载体,以深入研究VIM的功能及其在相关疾病中的作用。方法:从人cDNA文库中,以RT-PCR方法扩增出1401 bp的VIM编码区片段,胶回收后连接入T载体,测序鉴定。再用Hind III和BamH I双酶切,将VIM编码区片段定向克隆到真核表达载体pcDNA3.1中,酶切鉴定重组质粒。将重组质粒转染NIH3T3细胞,分别以RT-PCR和Western Blot方法检测VIM的mRNA表达和蛋白表达。结果:将人VIM编码区基因成功克隆到真核表达载体pcDNA3.1中;继而转染NIH3T3细胞后,RT-PCR和Western Blot结果显示细胞可以表达VIM的mRNA和蛋白。结论:成功构建pcDNA3.1-VIM的真核表达载体,为进一步研究VIM基因的功能以及其在相关疾病中的作用奠定了基础。 Objective: To build eukaryotic expression plasmid of VIM (Vimentin) gene in order to investigate the function of VIM gene and its role in related diseases. Methods: VIM coding region of 1401 bp was amplified from human cDNA library by RT-PCR, cloned the gel-extracted fragment into T-vector, and then identified by sequencing. Thereafter, VIM CDS fragment was cut down by Hind III and BamH I, and was then sub-cloned into eukaryotic expression plasmid pcDNA3.1. The recombinant plasmid was identified with Hind III and BarnH I cutting then transfected into NIH3T3 cells via liposome. The expression of VIM was detected by RT-PCR for the mRNA transcription and by Western Blot for the protein expression. Results: VIM coding region fragment had been successfully cloned into eukaryotic expression plasmid pcDNA3.1. The recombinant plasmid was transfected into NIH3T3 cells, and the results by RT-PCR and Western Blot showed that those transfected cells could produce VIM mRNA and protein. Conclusions: Eukaryotlc expression plasmid pcDNA3.1-VIM had been successfully constructed, which will be helpful for the further investigation of the function of VIM gene and its role in related diseases.
出处 《现代生物医学进展》 CAS 2013年第9期1615-1617,1614,共4页 Progress in Modern Biomedicine
关键词 VIM基因 基因克隆 真核表达 VIM gene Gene cloning Eukaryotic expression
  • 相关文献

参考文献16

  • 1Clarke EJ, Allan V. Intermediate filaments: vimentin moves in[J]. Cu- rr Biol,2002,12(17):596-598.
  • 2Sabbah M, Emami S, Redeuilh G, et al. Molecular signature and thera- peutic perspective of the epithelial-to-mesenchymal transitions in epith- elial cancers[J]. Drug Resist Updat, 2008, 11(4-5): 123-151.
  • 3Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy[J]. Cell Mol Life Sci, 2011,68(18):3033-3046.
  • 4Luime J J, Colin EM, Hazes JM, et al. Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnost- ic and prognostic investigation of patients with rheumatoid arthritis? A systematic review[J]. Ann Rheum Dis, 2010, 69(2):337-344.
  • 5Malakoutikhah M, G6mara M J, G6mez-Puerta JA, et al. The use of ch- imeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis[J]. J Med Chem, 2011, 54(21):7486-7492.
  • 6Vossenaar ER, Desprs N, Lapointe E, et al. Rheumatoid arthritis spe- cific anti-Sa antibodies target citrullinated vimentin [J]. Arthritis Res Ther, 2004, 6(2): 142-150.
  • 7邢艳丽,李静,耿美玉.细胞迁移中微丝微管的变化及其信号转导通路研究进展[J].现代生物医学进展,2007,7(6):919-922. 被引量:6
  • 8Fuchs E, Weber K. Intermediate filaments: structure, dynamics, functi- on, and disease[J]. Annu Rev Biochem,1994, 63:345-382.
  • 9Franke WW, Grund C, Kuhn C, et al. Formation of cytoskeletal eleme- nts during mouse embryogenesis. IlL Primary mesenchymal cells and the first appearance ofvimentin filaments[J]. Differentiation,1982, 23: 43-59.
  • 10Larsson A, Wilhelmsson U, Pekna M, et al. Increased cell proliferati- on and neurogenesis in the hippocampal dentate gyrus of old GFAP (-/-)Vim(-/-) mice[J]. Neurochem Res, 2004, 29:2069-2073.

二级参考文献68

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部